Harvard research funding has been thrust into the spotlight following a contentious stop-work order that disrupted critical projects at the prestigious institution.This order, directly impacting prominent organ-on-a-chip technology initiatives led by renowned scientist Don Ingber, was issued amid a heated political backdrop, representing a significant challenge to American innovation.